SCHEMBL25401428

SCHEMBL25401428

CN[C@@H]1CCO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17392981 1.00
SCHEMBL26095297 1.00
SCHEMBL283035 0.79
SCHEMBL283034 0.79
SCHEMBL429455 0.79
Methane SCHEMBL28591036 0.77
SCHEMBL487100 0.77
Hydrochloric Acid SCHEMBL29133641 0.75
SCHEMBL8182891 0.75
SCHEMBL30242100 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4650353-A1 4-ALKOXY BENZIMIDAZOLE-6-CARBOXYLIC ACID DERIVATIVE SERVING AS GLP-1 RECEPTOR AGONIST Shanghai Institute of Materia Medica, Chinese Academy of Sciences (CN) 2025-11-19 EP disclosed
WO-2025021048-A1 POLYCYCLIC COMPOUND AND USE THEREOF 石药集团中奇制药技术(石家庄)有限公司 2025-01-30 WO disclosed
WO-2024149080-A1 4-ALKOXY BENZIMIDAZOLE-6-CARBOXYLIC ACID DERIVATIVE SERVING AS GLP-1 RECEPTOR AGONIST 中国科学院上海药物研究所 2024-07-18 WO disclosed
CN-118344349-A 4-Alkoxybenzimidazole-6-carboxylic acid derivatives as GLP-1 receptor agonists 中国科学院上海药物研究所 2024-07-16 CN disclosed
CN-118271300-A Lactam compound, and preparation method and application thereof 广州市联瑞制药有限公司 2024-07-02 CN disclosed
CN-118271299-A Lactam compound, and preparation method and application thereof 广州市联瑞制药有限公司 2024-07-02 CN disclosed
CN-113493447-B GLP-1 receptor agonists 轩竹(北京)医药科技有限公司 2024-06-11 CN disclosed
CN-118084936-A Three-ring-containing compound and application thereof 石药集团中奇制药技术(石家庄)有限公司 2024-05-28 CN disclosed
CN-117903088-A Preparation method of (S) -oxetane-2-methylamine 南京药石科技股份有限公司 2024-04-19 CN disclosed
CN-117903088-A Preparation method of (S) -oxetane-2-methylamine 南京药石科技股份有限公司 2024-04-19 CN disclosed
CN-116217522-A Chiral purification method of key intermediate of GLP-1 receptor agonist 广东莱佛士制药技术有限公司 2023-06-06 CN disclosed
CN-116102543-A GLP-1R agonist, synthesis method and application thereof 江南大学 2023-05-12 CN disclosed
CN-116082321-A Imidazo-aryl derivative, pharmaceutical composition and application thereof 华中药业股份有限公司 2023-05-09 CN disclosed
WO-2023066356-A1 COMPOUND AS GLP-1 RECEPTOR AGONIST AND USE THEREOF 盛世泰科生物医药技术(苏州)有限公司 2023-04-27 WO disclosed
WO-2023065434-A1 PREPARATION METHOD FOR OXETANE-2-METHYLAMINE 韶远科技(上海)有限公司 2023-04-27 WO disclosed
CN-116003393-A Compounds as GLP-1 receptor agonists and uses thereof 盛世泰科生物医药技术(苏州)有限公司 2023-04-25 CN disclosed
CN-115991685-A Preparation method of oxetane-2-methylamine 韶远科技(上海)有限公司 2023-04-21 CN disclosed
CN-115521297-A 5,6-dihydro-1,2,4-triazines and their pharmaceutical use as GLP-1 receptor agonists 中国科学院上海药物研究所 2022-12-27 CN disclosed
WO-2022228490-A1 POLYCYCLIC DERIVATIVE MODULATOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翰森生物医药科技有限公司 2022-11-03 WO disclosed
CN-114716423-A 5, 6-dihydro-1, 2, 4-triazines and their pharmaceutical use as GLP-1 receptor agonists 中国科学院上海药物研究所 2022-07-08 CN disclosed